跳至主要内容
临床试验/NCT04117191
NCT04117191已完成不适用

Exploring the Mechanisms of Indoxyl Sulfate Production by Oral Tryptophan Challenge Test

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2019年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
2
主要终点
Indoxyl sulfate

研究概览

简要总结

Cardiovascular disease (CVD) is prevalent in patients with chronic kidney disease (CKD) and is associated with extremely poor prognosis. Traditional risk factors for the general population, such as diabetes mellitus, high blood pressure, and dyslipidemia, are more common in patients with CKD but cannot fully explain the increased risk of this population. New evidence suggests that the uremic milieu itself plays a critical role in the development and progression of CVD. The gut microbiota is markedly altered in CKD, with overgrowth of bacteria that produce uremic toxins. Indoxyl sulfate (IS) is among the most representative gut-derived uremic toxins and has been most frequently implicated as a contributor to the pathogenesis of CVD in CKD. IS is converted from indole, a gut bacteria metabolite of dietary tryptophan, by two hepatic enzymes, CYP2E1 and SULT1A1. The majority of studies have assessed IS toxicity in cultured cells and animal models. However, human data have been conflicting and the benefit of using orally administered adsorbents to reduce IS levels in unselected CKD patients was not supported by results from the recent randomized controlled trials. IS levels may fluctuate widely from time to time with dietary intakes. The investigators hypothesize that a postprandial IS concentration may more reflect its toxicity than a single time point (fasting or predialysis IS) concentration measured in clinical studies. Therefore, the investigators plan to establish an oral tryptophan challenge test (OTCT) by using an oral loading of 2 gm tryptophan to simulate the postprandial increase of plasma IS. The investigators will recruit 60 healthy volunteers to undergo OTCT. A pharmacokinetic study of IS after the OTCT will be performed in 20 of them to verify and simplify the design of OTCT protocol. The results of OTCT will be integrated with whole metagenome analysis of fecal microbiota and genetic polymorphism analysis of CYP2E1 and SULT1A1 to explore the mechanisms of IS production. In addition to the known genes in microbe produces indoles, other supporting bacteria or genes will be examined by using metagenomic shotgun sequencing data.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (1) age older than 20 years
  • (2) no exposure to antibiotics or probiotics within the 3 months before entering the study.

排除标准

  • (1) recent gastrointestinal discomfort (such as nausea, vomiting, abdominal pain, constipation, or diarrhea) or
  • (2) a history of chronic diseases including diabetes mellites, hypertension, CVD, CKD, liver disease, malignancy, and autoimmune disease.
  • (3) pregnancy or breast feeding
  • (4) currently use of antipsychotics, Hypnotics, Demerol, Dextromethorphan, tramadol, pentazocine

结局指标

主要结局

Indoxyl sulfate

时间窗: the area under curve of serum and urine indoxyl sulfate within 72 hours

serum and urine indoxyl sulfate concentration measurement

次要结局

  • Indole-3-acetic acid(the area under curve of serum and urine Indole-3-acetic acid within 72 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ting-Yun Lin

Nephrologist

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

研究点 (2)

Loading locations...

相似试验

Exploring the Mechanisms of Indoxyl Sulfate... | 临床试验